Trademark: 88955542
Word
GLOBAL PATHOGEN SHIELD
Status
Dead
Status Code
606
Status Date
Monday, August 5, 2024
Serial Number
88955542
Mark Type
4
Filing Date
Tuesday, June 9, 2020
Published for Opposition
Tuesday, May 4, 2021
Abandoned Date
Monday, August 5, 2024

Trademark Owner History
Flagship Pioneering, Inc. - Owner At Publication

Classifications
41 educational services, namely, conducting classes, seminars, and workshops in the field of public health and research and development related to infectious disease and distribution of educational materials in connection therewith; education services, namely, providing on-line instruction in the field of public health and the prevention, infection, and detection of infectious disease via an online website; educational services, namely, conducting classes, seminars, conferences and workshops in the fields of pharmaceutical and biotechnological product development, medical device development, public health, chronic diseases, infectious diseases, and economic development; educational services, namely, developing curriculum for others in the field of medical research; developing trainings for others regarding safety and health measures and preparing screening and monitoring protocols to address exposure to infectious disease
9 Diagnostic products and devices for use in detecting infectious disease, namely, diagnostic apparatus for the detection of pathogens for laboratory and research use; downloadable software for tracking and reporting incidence of infectious disease; downloadable software for use in the analysis of health and environmental data; downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; research and development tools relating to infectious diseases for research facilities and vaccine manufacturing facilities, namely, research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluids; research tools, namely, downloadable software for use in conducting infectious disease and public health research; research tools, namely, downloadable electronic databases in the field of infectious disease and public health research; scientific collaboration tools for researching and testing treatments for infectious disease, namely, downloadable computer software for collaborating on shared documents and data; surveillance tools for infectious disease being tools for monitoring infectious disease, namely, downloadable software featuring disease spread analytics and graphics, downloadable databases featuring disease spread analytics and graphics; electronic tools in the nature of downloadable software used to predict, identify and characterize pathogen threats to individuals and populations
5 diagnostic products for use in detecting and treating infectious disease, namely, medical diagnostic reagents and diagnostic preparations for medical purposes
35 Promoting collaboration within the scientific, research and medical communities to achieve advances in the field of healthcare, via a consortium, collective, and initiative of companies that collaborate to globally prevent, detect, and treat infectious disease; providing a website featuring business information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; maintaining a registry of participants on the Internet for clinical research relating to the prevention, infection, and detection of infectious disease; healthcare management and consulting services in connection with infectious disease, namely, business and management consulting for healthcare providers and related businesses and consulting in the field of healthcare operations management; developing worksite specific epidemic risk scoring profiles, namely, business risk management and healthcare business risk management consultation; consulting on healthcare public relations communication strategies; new investment and business models to drive research and development and innovation in the infectious disease space, namely, business advisory services and business consultancy with regard to reducing the spread of infectious diseases
45 subscription-based security system to prevent, detect, treat infectious disease being emergency response alarm monitoring services, namely, monitoring of alert devices by a remote monitoring center for the dispatch of emergency public health services and notification to third parties
44 Providing a website featuring medical and health information about infectious disease; providing an on-line computer database featuring medical and health information in the field of infectious disease; subscription-based security system to prevent, detect, treat infectious disease, namely, an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; consulting services in the field of healthcare in connection with infectious disease; developing worksite specific epidemic risk scoring profiles in the nature of healthcare consultation in the field of infectious diseases; providing a website featuring healthcare information about recruiting participants for clinical research and maintaining a consortium relating to the prevention, infection, and detection of infectious disease; new investment and business models to drive research and development and innovation in the infectious disease space, namely, healthcare advisory services and healthcare consultancy with regard to reducing the spread of infectious diseases
42 Providing an on-line computer database featuring medical research information in the field of infectious disease; research and development in the field of infectious diseases for research facilities and vaccine manufacturing facilities; research and development in the field of pharmaceutical and therapeutic development and medical device development; clinical research services in the field of medical care, namely, conducting clinical trials for others and scientific research; medical research in the nature of conducting laboratory, clinical and public health research, all for the medical and biomedical fields in the fields of infectious diseases and vaccines sciences, population science, and health systems research; providing temporary use of online, non-downloadable software for tracking and reporting incidence of infectious disease; providing temporary use of online, non-downloadable software for use in the analysis of health and environmental data; providing temporary use of online, non-downloadable software for use in the analysis of healthcare data from patients to determine rates, trends, patterns, and causative factors contributing to incidence of infectious disease; scientific and medical research in the fields of health, healthcare, infection prevention and control, and infectious diseases; product research, design and development in the fields health, healthcare, infection prevention and control, and infectious diseases; product research, design and development of medical devices, products and technologies in the fields of health, healthcare, infection prevention and control, and infectious diseases; design and development of healthcare products to improve healthcare services and build health systems; quality management services, namely, quality evaluation and analysis, quality assurance, quality control and product quality improvement, all in the fields of health, healthcare, infection prevention and control, and infectious diseases; developing quality control and voluntary standards and guidelines being protocols to address exposure to infectious disease, all for the delivery and rendition of healthcare services; developing worksite specific epidemic risk scoring profiles in the nature of scientific research consultation in the field of infectious diseases; developing intervention protocols, namely, development of voluntary standards for addressing exposure of infectious disease; research tools, namely, providing temporary use of online, non-downloadable software for use in conducting infectious disease and public health research; research tools, namely, providing an online searchable databases in the field of infectious disease and public health medical and scientific research; scientific collaboration tools and services for researching and testing treatments for infectious disease, namely, providing temporary use of a non-downloadable web application for collaborating on shared documents and data; surveillance tools and services for infectious disease being tools for monitoring infectious disease, namely, providing temporary use of online non-downloadable software for use in environmental monitoring and sampling air or surfaces
"GLOBAL PATHOGEN"

Trademark Events
Sep 15, 2020
Non-Final Action Written
Jul 2, 2020
New Application Office Supplied Data Entered
Sep 11, 2020
Assigned To Examiner
Sep 15, 2020
Non-Final Action E-Mailed
Sep 15, 2020
Notification Of Non-Final Action E-Mailed
Dec 4, 2020
Teas Response To Office Action Received
Dec 4, 2020
Correspondence Received In Law Office
Dec 5, 2020
Teas/Email Correspondence Entered
Dec 28, 2020
Final Refusal Written
Dec 28, 2020
Final Refusal E-Mailed
Dec 28, 2020
Notification Of Final Refusal Emailed
Mar 26, 2021
Teas Request For Reconsideration Received
Mar 26, 2021
Correspondence Received In Law Office
Mar 27, 2021
Teas/Email Correspondence Entered
Apr 1, 2021
Examiners Amendment -Written
Apr 1, 2021
Examiners Amendment E-Mailed
Apr 1, 2021
Notification Of Examiners Amendment E-Mailed
Apr 1, 2021
Examiner's Amendment Entered
Apr 1, 2021
Approved For Pub - Principal Register
Apr 14, 2021
Notification Of Notice Of Publication E-Mailed
Apr 23, 2021
Teas Petition To Director Received
May 4, 2021
Published For Opposition
May 4, 2021
Official Gazette Publication Confirmation E-Mailed
May 20, 2021
Assigned To Petition Staff
Jun 8, 2021
Petition To Director Denied
Jun 29, 2021
Noa E-Mailed - Sou Required From Applicant
Dec 22, 2021
Sou Teas Extension Received
Dec 22, 2021
Sou Extension 1 Filed
Dec 22, 2021
Sou Extension 1 Granted
Dec 24, 2021
Notice Of Approval Of Extension Request E-Mailed
May 2, 2022
Assigned To Examiner
Jun 27, 2022
Sou Teas Extension Received
Jun 27, 2022
Sou Extension 2 Filed
Jun 27, 2022
Sou Extension 2 Granted
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jul 15, 2022
Assigned To Examiner
Dec 27, 2022
Sou Teas Extension Received
Dec 27, 2022
Sou Extension 3 Filed
Dec 27, 2022
Sou Extension 3 Granted
Dec 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2023
Sou Teas Extension Received
Jun 27, 2023
Sou Extension 4 Filed
Jun 27, 2023
Sou Extension 4 Granted
Jun 29, 2023
Notice Of Approval Of Extension Request E-Mailed
Jan 12, 2024
Case Assigned To Intent To Use Paralegal
Dec 20, 2023
Sou Teas Extension Received
Dec 20, 2023
Sou Extension 5 Filed
Jan 12, 2024
Sou Extension 5 Granted
Jan 13, 2024
Notice Of Approval Of Extension Request E-Mailed
Aug 5, 2024
Abandonment - No Use Statement Filed
Aug 5, 2024
Abandonment Notice E-Mailed - No Use Statement Filed

Trademark Alertz updated from USPTO on 2030-01-24